` KMDA (Kamada Ltd) vs S&P 500 Comparison - Alpha Spread

KMDA
vs
S&P 500

Over the past 12 months, KMDA has outperformed S&P 500, delivering a return of +25% compared to the S&P 500's +14% growth.

Stocks Performance
KMDA vs S&P 500

Loading
KMDA
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
KMDA vs S&P 500

Performance Gap Between KMDA and GSPC
HIDDEN
Show

Performance By Year
KMDA vs S&P 500

Loading
KMDA
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Kamada Ltd vs Peers

S&P 500
KMDA
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Kamada Ltd
Glance View

Market Cap
405.5m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
HIDDEN
Show
Back to Top